A Phase III Double-Masked, Crossover, Vehicle-Controlled Clinical Trial Conducted in an Environmental Exposure Chamber (EEC) to Study Reproxalap, a Novel, Non-Antihistaminic, Non-Steroidal, Reactive Aldehyde Species Inhibitor for the Treatment for Allergic Conjunctivitis (AC)
Salapatek, Anne Marie, Goyal, Yasmeen, Bundele, Saili, Brady, Todd, Couroux, Peter
Published in Journal of allergy and clinical immunology (01.02.2022)
Published in Journal of allergy and clinical immunology (01.02.2022)
Get full text
Journal Article